News
Press Releases
Aug 01, 2019
Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Thursday, August 8, 2019
Jun 25, 2019
Tricida Announces Publication of Positive Long-Term Phase 3 Clinical Trial Results of Veverimer (TRC101) in The Lancet
Jun 05, 2019
Tricida to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
May 08, 2019
Tricida Announces First Quarter 2019 Financial Results
Apr 30, 2019
Tricida to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, May 8, 2019
Apr 08, 2019
Tricida Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 03, 2019
Tricida Announces Pricing of Public Offering of Common Stock
Apr 01, 2019
Tricida Announces Proposed Public Offering of Common Stock
Mar 28, 2019
Tricida Announces Positive Results From Long-Term Clinical Trial of TRC101 in Patients With CKD and Metabolic Acidosis
Mar 28, 2019
Tricida Announces $200 Million Debt Facility With Hercules Capital